King Luther Capital Management Corp boosted its holdings in Cameco Co. (NYSE:CCJ – Free Report) (TSE:CCO) by 16.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 998,734 shares of the basic materials company’s stock after acquiring an additional 140,885 shares during the quarter. King Luther Capital Management Corp owned 0.23% of Cameco worth $51,325,000 at the end of the most recent quarter.
Several other large investors have also recently added to or reduced their stakes in CCJ. S&CO Inc. boosted its stake in Cameco by 0.5% during the 4th quarter. S&CO Inc. now owns 565,431 shares of the basic materials company’s stock valued at $29,057,000 after purchasing an additional 2,860 shares in the last quarter. Ranch Capital Advisors Inc. bought a new position in Cameco during the 4th quarter valued at $342,000. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in Cameco by 3.5% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 264,343 shares of the basic materials company’s stock valued at $13,585,000 after purchasing an additional 8,909 shares in the last quarter. Amundi boosted its stake in Cameco by 1.5% during the 4th quarter. Amundi now owns 2,156,893 shares of the basic materials company’s stock valued at $110,821,000 after purchasing an additional 32,825 shares in the last quarter. Finally, Larson Financial Group LLC boosted its stake in Cameco by 37.4% during the 4th quarter. Larson Financial Group LLC now owns 830 shares of the basic materials company’s stock valued at $43,000 after purchasing an additional 226 shares in the last quarter. 70.21% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Several research firms have recently weighed in on CCJ. StockNews.com raised Cameco from a “sell” rating to a “hold” rating in a research note on Friday, February 21st. Royal Bank of Canada reissued an “outperform” rating and set a $90.00 price objective on shares of Cameco in a research note on Tuesday, March 4th. One equities research analyst has rated the stock with a hold rating, six have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, Cameco has a consensus rating of “Buy” and a consensus price target of $71.25.
Cameco Price Performance
NYSE CCJ opened at $40.72 on Tuesday. The company has a 50 day simple moving average of $48.59 and a 200-day simple moving average of $50.02. Cameco Co. has a 52-week low of $35.43 and a 52-week high of $62.55. The firm has a market capitalization of $17.72 billion, a price-to-earnings ratio of 145.42 and a beta of 1.04. The company has a debt-to-equity ratio of 0.20, a current ratio of 2.88 and a quick ratio of 1.26.
Cameco (NYSE:CCJ – Get Free Report) (TSE:CCO) last announced its quarterly earnings data on Thursday, February 20th. The basic materials company reported $0.26 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.26. The business had revenue of $845.54 million for the quarter, compared to the consensus estimate of $1.09 billion. Cameco had a net margin of 5.39% and a return on equity of 4.34%. Equities research analysts predict that Cameco Co. will post 1.27 earnings per share for the current fiscal year.
Cameco Company Profile
Cameco Corporation provides uranium for the generation of electricity. It operates through Uranium, Fuel Services, Westinghouse segments. The Uranium segment is involved in the exploration for, mining, and milling, purchase, and sale of uranium concentrate. The Fuel Services segment engages in the refining, conversion, and fabrication of uranium concentrate, as well as the purchase and sale of conversion services.
Featured Articles
- Five stocks we like better than Cameco
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- How to Protect Your Portfolio When Inflation Is Rising
- How to Use the MarketBeat Dividend Calculator
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- 3 REITs to Buy and Hold for the Long Term
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Receive News & Ratings for Cameco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cameco and related companies with MarketBeat.com's FREE daily email newsletter.